IP Library Patent Application 15440319
Patent Application
App. No. 15/440,319

SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/440,319
Abstract

The present invention provides for novel methods for regulating and detecting the cytosine methylation status of DNA. The invention is based upon identification of a novel and surprising catalytic activity for the family of TET proteins, namely TET1, TET2, TET3, and CXXC4. The novel activity is related to the enzymes being capable of converting the cytosine nucleotide 5-methylcytosine into 5-hydroxymethylcytosine by hydroxylation.

Claims (34)

1 . A method for detecting 5-methylcytosine in a nucleic acid comprising:

a) converting 5-methylcytosine to an acid beyond hydroxymethylation in the nucleic acid using enzymatic modification by a dioxygenase;

b) bisulfite sequencing the converted nucleic acid; and

c) detecting the 5-methylcytosine in the nucleic acid at positions where the acid is identified by reading a thymine in the converted nucleic acid where a cytosine is read when the nucleic acid is bisulfite sequenced but not converted.

2 . The method of claim 1 , wherein said dioxygenase is TET1, TET2, TET3, or a homologue thereof.

3 . The method of claim 1 , wherein the dioxygenase comprises SEQ ID NO: 1.

4 . The method of claim 1 , further comprising modifying 5-hydroxymethylctosine with a detectable label prior to converting 5-methylcytosine to the acid.

5 . The method of claim 4 , further comprising detecting 5-hydroxymethylcytosine.

6 . The method of claim 1 , wherein the nucleic acid is genomic DNA.

7 . A method of detecting 5-hydroxymethylcytosine from 5-methylctosine from a nucleic acid comprising:

a) modifying 5-hydroxymethycytosine in the nucleic acid with a glucose or a modified glucose;

b) treating the modified nucleic acid with dioxygenase to convert 5-methylcytosine to an acid beyond hydroxymethylation;

c) sequencing the treated nucleic acid using bisulfite sequencing; and

d) detecting 5-hydroxymethylcytosine from 5-methylcytosine by reading a cytosine for 5-hydroxymethylcytosine and a thymine for 5-methylcytosine in the bisulfite sequenced nucleic acid.

8 . The method of claim 7 , wherein said dioxygenase is TET1, TET2, TET3, or a homologue thereof.

9 . The method of claim 7 , wherein the 5-hydroxymethylcytosine is modified by a process comprising incubating the nucleic acid with beta-glucosyltransferase, a radiolabeled glucose, or a glucose donor substrate.

10 . The method of claim 7 , wherein the nucleic acid is genomic DNA.

11 . A method for detecting 5-methylcytosine in a nucleic acid comprising:

a) converting 5-methylcytosine to an acid beyond hydroxymethylation in the nucleic acid using enzymatic modification by a dioxygenase;

b) bisulfite sequencing the converted nucleic acid; and

c) detecting the 5-methylcytosine in the nucleic acid at positions where the acid is identified by reading a thymine in the converted nucleic acid.

12 . The method of claim 11 , wherein said dioxygenase is TET1, TET2, TET3, or a homologue thereof.

13 . The method of claim 11 , wherein the dioxygenase comprises SEQ ID NO: 1.

14 . The method of claim 11 , further comprising modifying 5-hydroxymethylctosine with a detectable label.

15 . The method of claim 14 , further comprising detecting 5-hydroxymethylcytosine.

16 . The method of claim 11 , wherein the nucleic acid is genomic DNA.

17 . A method of detecting 5-hydroxymethylcytosine from 5-methylctosine from a nucleic acid comprising:

a) modifying 5-hydroxymethycytosine in the nucleic acid with a glucose or a modified glucose;

b) treating the modified nucleic acid with dioxygenase to convert 5-methylcytosine to an acid beyond hydroxymethylation;

c) sequencing the treated nucleic acid using bisulfite sequencing; and

d) detecting 5-hydroxymethylcytosine from 5-methylcytosine based on the bisulfite sequenced nucleic acid.

18 . The method of claim 17 , wherein said dioxygenase is TET1, TET2, TET3, or a homologue thereof.

19 . The method of claim 17 , wherein the 5-hydroxymethylcytosine is modified by a process comprising incubating the nucleic acid with beta-glucosyltransferase, a radiolabeled glucose, or a glucose donor substrate.

20 . The method of claim 17 , wherein the nucleic acid is genomic DNA.

Assignments (6)
CONFIRMATORY LICENSE Recorded Dec 23, 2019
From: BOSTON CHILDREN'S HOSPITAL
To: NIH-DEITR
Reel/Frame 051355/0822 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2017
From: IYER, ARAVIND
To: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 043585/0255 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 6, 2017
From: RAO, ANJANA; TAHILIANI, MAMTA; KOH, KIAN PENG
To: IMMUNE DISEASE INSTITUTE, INC.
Reel/Frame 043506/0504 →
MERGER Recorded Sep 6, 2017
From: IMMUNE DISEASE INSTITUTE, INC.
To: THE CHILDREN'S HOSPITAL CORPORATION
Reel/Frame 043506/0508 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 6, 2017
From: THE CHILDREN'S HOSPITAL CORPORATION
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 043506/0535 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 6, 2017
From: AGARWAL, SUNEET
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 043506/0539 →